市場調查報告書

全球血漿分餾市場:各產品、用途、終端用戶 - 機會分析,及產業預測(2018年∼2028年)

Global Plasma Fractionation Market by Product, Application, End User: Global Opportunity Analysis and Industry Forecast, 2018-2028

出版商 Allied Market Research 商品編碼 920145
出版日期 內容資訊 英文 205 Pages
商品交期: 2-3個工作天內
價格
全球血漿分餾市場:各產品、用途、終端用戶 - 機會分析,及產業預測(2018年∼2028年) Global Plasma Fractionation Market by Product, Application, End User: Global Opportunity Analysis and Industry Forecast, 2018-2028
出版日期: 2019年11月10日內容資訊: 英文 205 Pages
簡介

全球血漿分餾市場在2018年估算為168億2,300萬美金。該市場在2019年∼2026年間,預測將以6.1%的年複合成長率成長,2026年達到305億3,600萬美元的規模。

本報告提供全球血漿分餾市場的相關調查,市場機會,成長及阻礙因素,各產品、用途、終端用戶、各國市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 報告的說明
  • 對利害關係者而言的主要優點
  • 主要市場區隔
    • 本報告刊載的主要企業清單
  • 調查方法
    • 二次調查
    • 一次調查
    • 分析師的工具、模式

第2章 摘要整理

  • 主要調查結果
  • Cxo的見解

第3章 市場概要

  • 市場定義、範圍
  • 主要調查結果
    • 主要的投資品牌
  • 波特的五力分析
    • 買主談判力
    • 供應商談判力
    • 新生的話
    • 替代威脅
    • 產業內的競爭
  • 主要企業的地位
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 影響分析

第4章 市場分析:各產品

  • 概要
    • 市場規模、預測
  • 白蛋白
    • 主要市場趨勢及成長機會
    • 各國
  • 免疫球蛋白
    • 主要市場趨勢及成長機會
    • 各類型
    • 各國
  • 凝血因子Viii
    • 主要市場趨勢及成長機會
    • 各國

第5章 市場分析:各用途

  • 概要
    • 市場規模、預測
  • 神經學
  • 免疫學
  • 重症加護
  • 其他

第6章 市場分析:各終端用戶

  • 概要
    • 市場規模、預測
  • 醫院
  • 臨床研究所

第7章 市場分析:各國

  • 概要
    • 市場規模、預測
  • 俄羅斯
    • 主要市場趨勢及成長機會
    • 各產品
    • 各用途
    • 各終端用戶
  • 哈薩克
  • 印尼
  • 中國(含台灣)
  • 印度
  • 沙烏地阿拉伯
  • 埃及
  • 越南
  • 阿根廷
  • 泰國
  • 奈及利亞
  • 其他地區

第8章 企業簡介

  • Baxter International Inc.
    • 企業概要
    • 企業簡介
    • 業務部門
    • 產品系列
    • 業績
  • Bio Products Laboratory
  • Biotest Ag
  • CSL Ltd.
  • Grifols Sa
  • Kedrion Biopharma
  • Lfb S. A
  • Octapharma
  • Sanquin Blood Supply Foundation
  • 武田藥品工業株式會社

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The global plasma fractionation market was valued at $16,823 million in 2018, and is expected to reach $30,536 million by 2026, registering a CAGR of 6.1% from 2019 to 2026.

Fractionation is a mechanical process carried out to separate a certain quantity of mixture. Plasma is the liquid part of the blood which is yellowish and holds blood cells. Plasma fractionation is carried out to separate high quality, proteinaceous products such as albumin, immunoglobulins, and others. These derived products are known as plasma derivatives obtained from fractionation. Moreover, these products are used in various medical fields such as in neurology, hematology, critical care, immunology, and others. For instance, in critical care, plasma is prescribed to prevent and stop bleeding. In addition, plasma products are widely used in clinical research laboratories and hospitals.

The factors that boost the growth of the plasma fractionation market include surge in geriatric population across the globe, which is predisposed to various rare diseases that require the use of plasma derivatives. Moreover, rise in use of immunoglobulins and alpha-1-antitrypsin in areas of medicine worldwide also fuel the growth of the plasma fractionation market. Furthermore, surge in plasma collection centers worldwide is another major factor that contributes toward the growth of this market.

In addition, favorable governmental support to spread awareness related to the use of plasma derived products also fuels the growth of the plasma fractionation market. However, high cost of plasma derived products restricts the growth of the market. Conversely, growth potential in emerging economies is expected to create lucrative opportunities for the market growth during the forecast period.

The global plasma fractionation market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is divided into albumin, immunoglobulins, and coagulation factor VIII. Moreover, immunoglobulins are further divided into subcutaneous immunoglobulin (SCIG) and coagulation factor VIII. By application, the market is classified into neurology, hematology, immunology, critical care, and others. On the basis of end user, it is categorized into hospitals and clinical research laboratories. By country, it is analyzed across Russia, Kazakhstan, Indonesia, China (Including Taiwan), India, Saudi Arabia, Egypt, Vietnam, Argentina, Thailand, and Nigeria.

KEY BENEFITS FOR STAKEHOLDERS

  • This report entails a detailed quantitative analysis along with the current global plasma fractionation market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

  • By Product
  • Albumin
  • Immunoglobulins
  • Subcutaneous Immunoglobulin (SCIG)
  • Intravenous Immunoglobulin (IVIG)
  • Coagulation Factor
  • By Application
  • Neurology
  • Hematology
  • Immunology
  • Critical Care
  • Others
  • By End User
  • Hospitals
  • Clinical Research Laboratories
  • By Country
  • Russia
  • Kazakhstan
  • Indonesia
  • China (Including Taiwan)
  • India
  • Saudi Arabia
  • Egypt
  • Vietnam
  • Argentina
  • Thailand
  • Nigeria
  • Rest of the World

List of key players profiled in the report:

  • Grifols SA
  • Baxter International Inc
  • CSL LTD.
  • Bio Product Laboratory
  • Octapharma AG
  • Sanquin
  • Laboratoire Franais Du Fractionnement Et Des
  • Kedrion
  • Biotest
  • Takeda Pharmaceuticals
  • LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • LFB S.A.
  • Shanghai RAAS Blood Products Co., Ltd.

Table of Contents

Chapter 1: Introduction

  • 1.1. Report Description
  • 1.2. Key Benefits For Stakeholders
  • 1.3. Key Market Segments
    • 1.3.1. List Of Key Players Profiled In The Report
  • 1.4. Research Methodology
    • 1.4.1. Secondary Research
    • 1.4.2. Primary Research
    • 1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

  • 2.1. Key Findings Of The Study
  • 2.2. Cxo Perspective

Chapter 3: Market Overview

  • 3.1. Market Definition And Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
  • 3.3. Porter'S Five Forces Analysis
    • 3.3.1. Bargaining Power Of Buyers
    • 3.3.2. Bargaining Power Of Suppliers
    • 3.3.3. Thereat Of New Entrants
    • 3.3.4. Threat Of Substitutes
    • 3.3.5. Intensity Of Competitive Rivalry
  • 3.4. Top Player Positioning, 2018
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
      • 3.5.1.1. Surge In Geriatric Population Across The Globe Coupled With Rise In Prevalence Of Rare Diseases
      • 3.5.1.2. Rise In Use Of Immunoglobulins In Areas Of Medicine
      • 3.5.1.3. Increase In Number Of Plasma Collection Centers Across The Globe
    • 3.5.2. Restraint
      • 3.5.2.1. High Cost Of Plasma Derived Products
    • 3.5.3. Opportunity
      • 3.5.3.1. High Growth Potential In Emerging Economies
    • 3.5.4. Impact Analysis

Chapter 4: Plasma Fractionation Market, By Product

  • 4.1. Overview
    • 4.1.1. Market Size And Forecast
  • 4.2. Albumin
    • 4.2.1. Key Market Trends And Growth Opportunities
    • 4.2.2. Market Size And Forecast, By Country
  • 4.3. Immunoglobulins
    • 4.3.1. Key Market Trends And Growth Opportunities
    • 4.3.2. Market Size And Forecast, By Type
      • 4.3.2.1. Subcutaneous Immunoglobulin
      • 4.3.2.1.1. Market Size And Forecast
      • 4.3.2.2. Intravenous Immunoglobulin
      • 4.3.2.2.1. Market Size And Forecast
    • 4.3.3. Market Size And Forecast, By Country
  • 4.4. Coagulation Factor Viii
    • 4.4.1. Key Market Trends And Growth Opportunities
    • 4.4.2. Market Size And Forecast, By Country

Chapter 5: Plasma Fractionation Market, By Application

  • 5.1. Overview
    • 5.1.1. Market Size And Forecast
  • 5.2. Neurology
    • 5.2.1. Market Size And Forecast, By Region
  • 5.3. Hematology
    • 5.3.1. Market Size And Forecast, By Region
  • 5.4. Immunology
    • 5.4.1. Market Size And Forecast, By Region
  • 5.5. Critical Care
    • 5.5.1. Market Size And Forecast, By Region
  • 5.6. Others
    • 5.6.1. Market Size And Forecast, By Region

Chapter 6: Plasma Fractionation Market, By End User

  • 6.1. Overview
    • 6.1.1. Market Size And Forecast
  • 6.2. Hospitals
    • 6.2.1. Market Size And Forecast, By Region
  • 6.3. Clinical Research Laboratories
    • 6.3.1. Market Size And Forecast, By Region

Chapter 7: Plasma Fractionation Market, By Country

  • 7.1. Overview
    • 7.1.1. Market Size And Forecast
  • 7.2. Russia
    • 7.2.1. Key Market Trends And Growth Opportunities
    • 7.2.2. Market Size And Forecast, By Product
    • 7.2.3. Market Size And Forecast, By Application
    • 7.2.4. Market Size And Forecast, By End User
  • 7.3. Kazakhstan
    • 7.3.1. Key Market Trends And Growth Opportunities
    • 7.3.2. Market Size And Forecast, By Product
    • 7.3.3. Market Size And Forecast, By Application
    • 7.3.4. Market Size And Forecast, By End User
  • 7.4. Indonesia
    • 7.4.1. Key Market Trends And Growth Opportunities
    • 7.4.2. Market Size And Forecast, By Product
    • 7.4.3. Market Size And Forecast, By Application
    • 7.4.4. Market Size And Forecast, By End User
  • 7.5. China (Including Taiwan)
    • 7.5.1. Key Market Trends And Growth Opportunities
    • 7.5.2. Market Size And Forecast, By Product
    • 7.5.3. Market Size And Forecast, By Application
    • 7.5.4. Market Size And Forecast, By End User
  • 7.6. India
    • 7.6.1. Key Market Trends And Growth Opportunities
    • 7.6.2. Market Size And Forecast, By Product
    • 7.6.3. Market Size And Forecast, By Application
    • 7.6.4. Market Size And Forecast, By End User
  • 7.7. Saudi Arabia
    • 7.7.1. Key Market Trends And Growth Opportunities
    • 7.7.2. Market Size And Forecast, By Product
    • 7.7.3. Market Size And Forecast, By Application
    • 7.7.4. Market Size And Forecast, By End User
  • 7.8. Egypt
    • 7.8.1. Key Market Trends And Growth Opportunities
    • 7.8.2. Market Size And Forecast, By Product
    • 7.8.3. Market Size And Forecast, By Application
    • 7.8.4. Market Size And Forecast, By End User
  • 7.9. Vietnam
    • 7.9.1. Key Market Trends And Growth Opportunities
    • 7.9.2. Market Size And Forecast, By Product
    • 7.9.3. Market Size And Forecast, By Application
    • 7.9.4. Market Size And Forecast, By End User
  • 7.10. Argentina
    • 7.10.1. Key Market Trends And Growth Opportunities
    • 7.10.2. Market Size And Forecast, By Product
    • 7.10.3. Market Size And Forecast, By Application
    • 7.10.4. Market Size And Forecast, By End User
  • 7.11. Thailand
    • 7.11.1. Key Market Trends And Growth Opportunities
    • 7.11.2. Market Size And Forecast, By Product
    • 7.11.3. Market Size And Forecast, By Application
    • 7.11.4. Market Size And Forecast, By End User
  • 7.12. Nigeria
    • 7.12.1. Key Market Trends And Growth Opportunities
    • 7.12.2. Market Size And Forecast, By Product
    • 7.12.3. Market Size And Forecast, By Application
    • 7.12.4. Market Size And Forecast, By End User
  • 7.13. Rest Of The World
    • 7.13.1. Key Market Trends And Growth Opportunities
    • 7.13.2. Market Size And Forecast, By Product
    • 7.13.3. Market Size And Forecast, By Application
    • 7.13.4. Market Size And Forecast, By End User

Chapter 8: Company Profiles

  • 8.1. Baxter International Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Operating Business Segments
    • 8.1.4. Product Portfolio
    • 8.1.5. Business Performance
  • 8.2. Bio Products Laboratory
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Operating Business Segments
    • 8.2.4. Product Portfolio
  • 8.3. Biotest Ag
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Operating Business Segments
    • 8.3.4. Product Portfolio
    • 8.3.5. Business Performance
    • 8.3.6. Key Strategic Moves And Developments
  • 8.4. Csl Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Operating Business Segments
    • 8.4.4. Product Portfolio
    • 8.4.5. Business Performance
  • 8.5. Grifols Sa
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Operating Business Segments
    • 8.5.4. Product Portfolio
    • 8.5.5. Business Performance
  • 8.6. Kedrion Biopharma
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Operating Business Segments
    • 8.6.4. Product Portfolio
    • 8.6.5. Business Performance
  • 8.7. Lfb S. A
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Operating Business Segments
    • 8.7.4. Product Portfolio
    • 8.7.5. Business Performance
  • 8.8. Octapharma
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Operating Business Segments
    • 8.8.4. Product Portfolio
  • 8.9. Sanquin Blood Supply Foundation
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Operating Business Segments
    • 8.9.4. Product Portfolio
    • 8.9.5. Business Performance
  • 8.10. Takeda Pharmaceutical Company Limited
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Operating Business Segments
    • 8.10.4. Product Portfolio
    • 8.10.5. Business Performance
    • 8.10.6. Key Strategic Moves And Developments

List of Tables

List of Tables

Table 01. Global Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 02. Global Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 03. Plasma Fractionation Market For Albumin, By Country, 2016-2028 ($Million)

Table 04. Plasma Fractionation Market For Albumin, By Country, 2016-2028 (Metric Tons)

Table 05. Plasma Fractionation Market For Immunoglobulins, By Type, 2016-2028 ($Million)

Table 06. Plasma Fractionation Market For Immunoglobulins, By Type, 2016-2028 ($Million)

Table 07. Plasma Fractionation Market For Immunoglobulins, By Country, 2016-2028 ($Million)

Table 08. Plasma Fractionation Market For Immunoglobulins, By Country, 2016-2028 (Metric Tons)

Table 09. Plasma Fractionation Market For Coagulation Factor Viii, By Country, 2016-2028 ($Million)

Table 10. Plasma Fractionation Market For Coagulation Factor Viii, By Country, 2016-2028 (Million International Unit)

Table 11. Global Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 12. Global Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 13. Plasma Fractionation Market For Neurology, By Country, 2016-2028 ($Million)

Table 14. Plasma Fractionation Market For Neurology, By Country, 2016-2028 (Metric Tons)

Table 15. Plasma Fractionation Market For Hematology, By Country, 2016-2028 ($Million)

Table 16. Plasma Fractionation Market For Hematology, By Country, 2016-2028 (Metric Tons)

Table 17. Plasma Fractionation Market For Immunology, By Country, 2016-2028 ($Million)

Table 18. Plasma Fractionation Market For Immunology, By Country, 2016-2028 (Metric Tons)

Table 19. Plasma Fractionation Market For Critical Care, By Country, 2016-2028 ($Million)

Table 20. Plasma Fractionation Market For Critical Care, By Country, 2016-2028 (Metric Tons)

Table 21. Plasma Fractionation Market For Others, By Country, 2016-2028 ($Million)

Table 22. Plasma Fractionation Market For Others, By Country, 2016-2028 (Metric Tons)

Table 23. Global Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 24. Global Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons )

Table 25. Plasma Fractionation Market For Hospitals, By Country, 2016-2028 ($Million)

Table 26. Plasma Fractionation Market For Hospitals, By Country, 2016-2028 (Metric Tons )

Table 27. Plasma Fractionation Market For Clinical Research Laboratories, By Country, 2016-2028 ($Million)

Table 28. Plasma Fractionation Market For Clinical Research Laboratories, By Country, 2016-2028 (Metric Tons )

Table 29. Global Plasma Fractionation Market, By Country, 2016-2028 ($Million)

Table 30. Global Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 31. Russia Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 32. Russia Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 33. Russia Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 34. Russia Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 35. Russia Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 36. Russia Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 37. Kazakhstan Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 38. Kazakhstan Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 39. Kazakhstan Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 40. Kazakhstan Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 41. Kazakhstan Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 42. Kazakhstan Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 43. Indonesia Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 44. Indonesia Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 45. Indonesia Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 46. Indonesia Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 47. Indonesia Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 48. Indonesia Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 49. China Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 50. China Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 51. China Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 52. China Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 53. China Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 54. China Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 55. India Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 56. India Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 57. India Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 58. India Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 59. India Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 60. India Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 61. Saudi Arabia Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 62. Saudi Arabia Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 63. Saudi Arabia Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 64. Saudi Arabia Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 65. Saudi Arabia Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 66. Saudi Arabia Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 67. Egypt Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 68. Egypt Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 69. Egypt Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 70. Egypt Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 71. Egypt Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 72. Egypt Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 73. Vietnam Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 74. Vietnam Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 75. Vietnam Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 76. Vietnam Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 77. Vietnam Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 78. Vietnam Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 79. Argentina Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 80. Argentina Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 81. Argentina Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 82. Argentina Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 83. Argentina Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 84. Argentina Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 85. Thailand Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 86. Thailand Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 87. Thailand Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 88. Thailand Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 89. Thailand Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 90. Thailand Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 91. Nigeria Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 92. Nigeria Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 93. Nigeria Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 94. Nigeria Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 95. Nigeria Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 96. Nigeria Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 97. Rest of The World Plasma Fractionation Market, By Product, 2016-2028 ($Million)

Table 98. Rest of The World Plasma Fractionation Market, By Product, 2016-2028 (Metric Tons)

Table 99. Rest of The World Plasma Fractionation Market, By Application, 2016-2028 ($Million)

Table 100. Rest of The World Plasma Fractionation Market, By Application, 2016-2028 (Metric Tons)

Table 101. Rest of The World Plasma Fractionation Market, By End User, 2016-2028 ($Million)

Table 102. Rest of The World Plasma Fractionation Market, By End User, 2016-2028 (Metric Tons)

Table 103. Baxter: Company Snapshot

Table 104. Baxter: Product Segment

Table 105. Baxter: Product Portfolio

Table 106. Bio Products Laboratory: Company Snapshot

Table 107. Bio Products Laboratory: Operating Segments

Table 108. Bio Products Laboratory: Product Portfolio

Table 109. Biotest Ag: Company Snapshot

Table 110. Biotest Ag: Operating Segments

Table 111. Biotest Ag: Product Portfolio

Table 112. Csl Ltd..: Company Snapshot

Table 113. Csl Ltd..: Operating Segment

Table 114. Csl Ltd..: Product Portfolio

Table 115. Grifols Sa: Company Snapshot

Table 116. Grifols Sa: Operating Segments

Table 117. Grifols Sa: Product Portfolio

Table 118. Kedrion: Company Snapshot

Table 119. Kedrion: Operating Segments

Table 120. Kedrion: Product Portfolio

Table 121. Lfb S.A: Company Snapshot

Table 122. Lfb S.A: Operating Segments

Table 123. Lfb S.A: Product Portfolio

Table 124. Octapharma: Company Snapshot

Table 125. Octapharma: Operating Segments

Table 126. Octapharma: Product Portfolio

Table 127. Sanquin Blood Supply Foundation: Company Snapshot

Table 128. Sanquin Blood Supply Foundation: Operating Segments

Table 129. Sanquin Blood Supply Foundation: Product Portfolio

Table 130. Takeda: Company Snapshot

Table 131. Takeda: Product Portfolio

List of Figures

List of Figures

Figure 01. Global Plasma Fractionation Market Segmentation

Figure 02. Top Investment Pockets

Figure 03. Moderate Bargaining Power of Buyers

Figure 04. Low Bargaining Power of Suppliers

Figure 05. Low Threat of New Entrants

Figure 07. Moderate Competitive Rivalry

Figure 08. Top Player Positioning, 2018

Figure 09. World Population Aged 65 And Over (%)

Figure 10. Impact Analyses, Plasma Fractionation Market

Figure 11. Subcutaneous Immunoglobulin Market, 2016-2028 ($Million And Volume)

Figure 12. Intravenous Immunoglobulin Market, 2016-2028 ($Million And Volume)

Figure 13. Baxter: Net Sales, 2016-2018 ($Million)

Figure 14. Baxter: Revenue Share By Segments, 2018(%)

Figure 15. Baxter: Revenue Share By Region 2018(%)

Figure 16. Biotest Ag: Net Sales, 2016-2018 ($Million)

Figure 17. Biotest Ag: Revenue Share By Segment, 2018 (%)

Figure 18. Biotest Ag: Revenue Share By Region, 2018(%)

Figure 19. Csl Ltd.: Net Sales, 2016-2018 ($Million)

Figure 20. Csl Ltd.: Revenue Share By Segment, 2019(%)

Figure 21. Grifols Sa: Net Sales, 2016-2018 ($Million)

Figure 22. Grifols Sa: Revenue Share By Segment, 2018 (%)

Figure 23. Grifols Sa: Revenue Share By Region, 2018(%)

Figure 24. Kedrion: Net Sales, 2016-2018 ($Million)

Figure 25. Kedrion: Revenue Share By Region, 2018(%)

Figure 26. Lfb S.A: Net Sales, 2016-2018 ($Million)

Figure 27. Lfb S.A: Revenue Share By Segment, 2018 (%)

Figure 28. Sanquin Blood Supply Foundation: Net Sales, 2017-2018 ($Million)

Figure 29. Sanquin Blood Supply Foundation: Revenue Share By Segment, 2018 (%)

Figure 30. Sanquin Blood Supply Foundation: Revenue Share By Region, 2018 (%)

Figure 31. Takeda: Net Sales, 2017-2019 ($Million)

Figure 32. Takeda: Revenue Share By Segment, 2019 (%)

Figure 33. Takeda: Revenue Share By Region, 2019 (%)